What are cell and gene therapies? Cell and gene therapies are utilized to treat diseases and, in some cases, cure diseases by targeting the underlying proteins or genes. Overlaps between these ...

When it comes to the laboratory workflow, researchers typically leverage the best attributes of multiple analytical instruments to evaluate complex cell-based assays. However, advanced flow cytometers ...

Antibodies directed against the SARS-CoV-2 spike protein receptor binding domain (RBD) demonstrate potent neutralizing activity. Scientists have identified several classes of these antibodies in COVID ...

The past decade has seen an explosion in the number of antibody-based therapeutics on the market. A huge driver of this has been the advancement of technologies that improve the time and efficiency of ...

Multiplexed, multiparameter screening assays are foundational to the drug discovery process. By collecting more information, more rapidly – whether the focus antibodies, small molecules, or phenotypic ...

This handbook is designed as a go-to reference for every flow cytometry user. Scientists using traditional systems will learn how routine workflows can benefit from the speed, throughput, and ...

Antibody-based therapeutics are helping patients across a wide range of disease areas, from cancer, such as Rituximab treatment of CD20-positive non-Hodgkin's lymphomas, to infectious diseases like ...

Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...

What are cell and gene therapies? Cell and gene therapies are used to treat, and sometimes cure, diseases by addressing the underlying genes or proteins. While there is overlap between the fields, ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the global commercial launch of BD Research Cloud 7.0, marking another step forward in its AI-driven life sciences strategy ...